Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Different hair growth problems are caused by genetic issues or changes in hair growth cycles, and new treatments are being developed.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

The normal human prostate does not significantly affect blood DHT levels.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Men with baldness have higher levels of specific proteins, suggesting local hormone production may play a role in hair loss.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

Eating a balanced diet with specific nutrients is important for menopausal women to manage hair loss.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Acne and increased body hair in teenage girls are normal but severe cases may need hormone evaluation and treatment can prevent diabetes linked to PCO.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Finasteride doesn't affect antipyrine metabolism, so interactions with cytochrome P-450 enzyme drugs are unlikely.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Clascoterone may be a promising treatment for hair loss.

Hair ages due to various factors and treatments like minoxidil and finasteride can help, but more research and better public awareness are needed.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.